Trial Site Detail

 

Drug:
Nilotinib or Imatinib
Trial:
Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

University of Pittsburgh Cancer Institute

     
Pittsburgh , PA 15232
USA

 

Principal Investigator:
 Nathan Bahary, MD
Contact:
 Amy Schmotzer 412-647-6468 schmotzerar@upmc.edu
Activation Status of this Site:
 Closed
Notes about this Site:
University of Pittsburgh Cancer Institute Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.